Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.

Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.
复制标题

DOI:
10.1186/s12879-020-05681-5
复制
发表时间:
2020-12-21
影响因子:
3.7
通讯作者:
Lu FE
Lu FE
中科院分区:
医学3区
文献类型:
--
作者:
Gong J;Dong H;Xia QS;Huang ZY;Wang DK;Zhao Y;Liu WH;Tu SH;Zhang MM;Wang Q;Lu FE

文献摘要

参考文献

被引文献

相似文献

COVID-19具有高度传染性,危重患者的粗死亡率可达49%。炎症与疾病进展有关。该研究分析了轻症、重症和危重症患者的血液炎症指标,有助于早期识别重症或危重症患者。在这项横断面研究中,纳入了100名患者,并根据病情分为轻症组、重度组和危重症组。分析外周血炎症相关指标与病情危重度的相关性。通过ROC曲线推测危重患者的临界值。显着的是,疾病严重程度与年龄(R = -0.564,P < 0.001)、白细胞介素2受体(IL2R)(R = -0.534,P < 0.001)、白细胞介素6(IL-6)(R = -0.535, P < 0.001)、白细胞介素-8 (IL-8) (R = -0.308, P < 0.001)、白细胞介素 10 (IL-10) (R = -0.422, P < 0.001)、肿瘤坏死因子 α (TNFα) (R = -0.322,P < 0.001),C反应蛋白(CRP) (R = -0.604,P < 0.001),铁蛋白(R = -0.508,P < 0.001),降钙素原(R = -0.650,P < 0.001),白细胞计数 (WBC) (R = -0.54,P < 0.001),淋巴细胞计数 (LC) (R = 0.56,P < 0.001),中性粒细胞计数 (NC) (R = -0.585,P < 0.001)和嗜酸性粒细胞计数(EC)(R = 0.299,P < 0.001)。当IL2R> 793.5 U/mL或CRP> 30.7 ng/mL时,应密切观察并可能预防COVID-19进展到关键阶段。炎症与 COVID-19 的严重程度密切相关,IL-6 和 TNFα 可能是有希望的治疗靶点。
COVID-19 is highly contagious, and the crude mortality rate could reach 49% in critical patients. Inflammation concerns on disease progression. This study analyzed blood inflammation indicators among mild, severe and critical patients, helping to identify severe or critical patients early. In this cross-sectional study, 100 patients were included and divided into mild, severe or critical groups according to disease condition. Correlation of peripheral blood inflammation-related indicators with disease criticality was analyzed. Cut-off values for critically ill patients were speculated through the ROC curve. Significantly, disease severity was associated with age (R = -0.564, P < 0.001), interleukin-2 receptor (IL2R) (R = -0.534, P < 0.001), interleukin-6 (IL-6) (R = -0.535, P < 0.001), interleukin-8 (IL-8) (R = -0.308, P < 0.001), interleukin-10 (IL-10) (R = -0.422, P < 0.001), tumor necrosis factor α (TNFα) (R = -0.322, P < 0.001), C-reactive protein (CRP) (R = -0.604, P < 0.001), ferroprotein (R = -0.508, P < 0.001), procalcitonin (R = -0.650, P < 0.001), white cell counts (WBC) (R = -0.54, P < 0.001), lymphocyte counts (LC) (R = 0.56, P < 0.001), neutrophil count (NC) (R = -0.585, P < 0.001) and eosinophil counts (EC) (R = 0.299, P < 0.001). With IL2R > 793.5 U/mL or CRP > 30.7 ng/mL, the progress of COVID-19 to critical stage should be closely observed and possibly prevented. Inflammation is closely related to severity of COVID-19, and IL-6 and TNFα might be promising therapeutic targets.
DOI: 10.1016/s0140-6736(20)30183-5
发表时间: 2020-02-15
期刊: LANCET
影响因子: 168.9
作者:
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者: Cao, Bin
DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003
发表时间: 2020-02-21
期刊: CHINA CDC WEEKLY
影响因子: 4.7
作者:
Feng, Zijian;Li, Qun;McGoogan, Jennifer M.
通讯作者: McGoogan, Jennifer M.
DOI: 10.1136/bmj.m606
发表时间: 2020-02-19
影响因子: 105.7
作者:
Xu, Xiao-Wei;Wu, Xiao-Xin;Li, Lan-Juan
通讯作者: Li, Lan-Juan
DOI: 10.1016/s0140-6736(20)30211-7
发表时间: 2020-02-15
期刊: LANCET
影响因子: 168.9
作者:
Chen, Nanshan;Zhou, Min;Zhang, Li
通讯作者: Zhang, Li
DOI: 10.1016/j.ebiom.2020.102763
发表时间: 2020-05-01
期刊: EBioMedicine
影响因子: 11.1
作者:
Liu, Jing;Li, Sumeng;Zheng, Xin
通讯作者: Zheng, Xin